Silence Therapeutics SLN
NASDAQ SLN
$10.80 -0.40 (-3.57%)
At close: Sep 29, 2026 · 4:00 PM EDT

Silence Therapeutics (SLN) Operating Expenses (2024 - 2026)

Updated

Silence Therapeutics' Operating Expenses was $13.87 million in the quarter ended Jun 30, 2026, down 42.5% from $24.1 million a year earlier and down 14.1% from the prior quarter.

Analysis

Silence Therapeutics (SLN) Operating Expenses (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Silence Therapeutics' Operating Expenses was $68.84 million through Jun 30, 2026, down 36.3% year-over-year; for the year ended Dec 31, 2025, it was $91.42 million, down 3.5% from the prior year.

  • Operating Expenses shows a five-year compound annual growth rate of 15.8% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Operating Expenses was $94.77 million in the year ended Dec 31, 2024 (+18.1%), $80.25 million in the year ended Dec 31, 2023 (+17.4%), $68.33 million in the year ended Dec 31, 2022 (-2.2%) and $69.86 million in the year ended Dec 31, 2021 (+59.1%).
  • Quarterly Operating Expenses has moved between $12.48 million (the quarter ended Dec 31, 2025) and $28.5 million (the quarter ended Mar 31, 2025) over five years.
  • Compared with a year earlier, Operating Expenses has declined for four straight quarters, with an average decline of 12.7% over the last six quarters.
  • Per Business Quant data, SLN's Operating Expenses in the three quarters before the quarter ended Jun 30, 2026 was $16.15 million (quarter ended Mar 31, 2026), $12.48 million (quarter ended Dec 31, 2025) and $26.34 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Silence Therapeutics 529.16 Mn 457.06 Mn - 13.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.87 Mn
Mar 31, 2026 16.15 Mn
Dec 31, 2025 12.48 Mn
Sep 30, 2025 26.34 Mn
Jun 30, 2025 24.10 Mn
Mar 31, 2025 28.50 Mn
Dec 31, 2024 27.62 Mn
Sep 30, 2024 27.86 Mn
Jun 30, 2024 20.81 Mn
Mar 31, 2024 18.48 Mn
API Access

Silence Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=SLN&period=max&api_key=YOUR_API_KEY